文献速递脑血管病外科神经重症

既往破裂弹簧圈栓塞动脉瘤残留的血管内再治疗显著降低再出血率

Endovascular Retreatment of Previously Ruptured Coiled Cerebral Aneurysm Remnants Significantly Reduces Rebleed Rate.
PubMed 文献 · World Neurosurg · 2020-12-19

单中心2004—2015年回顾性分析214例首次Guglielmi可解脱弹簧圈栓塞的破裂脑动脉瘤,对未完全栓塞、弹簧圈压缩或瘤体扩大者行再治疗。46例(21.5%)需再治疗,平均再治疗时间9个月;再出血2例(0.9%),再治疗未导致新的长期神经功能缺损。

要点

  • 对栓塞后残留或再通动脉瘤积极再治疗,再出血率降至0.9%。
  • 再治疗主要针对弹簧圈压缩/残留增大、再通、持续残留及再出血。
  • 再治疗未引起新的长期神经功能缺损,附加病残率低。

核心结论

  • 对既往破裂、弹簧圈栓塞后持续通畅的脑动脉瘤积极再治疗,可将再出血风险降至历史开颅夹闭动脉瘤的水平,且附加病残率极低。
  • 本研究验证了治疗后动脉瘤残留与再出血相关的大量文献证据。

研究设计与样本

  • 单中心回顾性研究,纳入2004—2015年所有首次行Guglielmi可解脱弹簧圈栓塞的脑动脉瘤。
  • 共214个动脉瘤符合纳入标准,平均(标准差)随访2.74(2.24)年。
  • 采用Kaplan-Meier生存分析评估栓塞持久性。

主要发现

  • 46个(21.5%)动脉瘤需要再治疗,平均(标准差)再治疗时间为9(9)个月。
  • 再治疗原因包括弹簧圈压缩/残留增大、再通、持续残留和再出血。
  • 2例(0.9%)患者发生复发性动脉瘤出血,均接受额外弹簧圈栓塞治疗。
  • 再治疗未导致新的长期神经功能缺损。

关键数值与推荐

  • 历史对照再出血率为2.3%—3.0%,本研究再出血率为0.9%。
  • 对不完全栓塞(含初始栓塞不全、弹簧圈压缩、动脉瘤扩张)常规行再治疗。
  • 动脉瘤再破裂以额外弹簧圈栓塞治疗。

临床怎么用

  • 栓塞后应规律随访,发现残留、再通或弹簧圈压缩时积极再治疗。
  • 再治疗以额外弹簧圈栓塞为主,需权衡其低附加风险与降低再出血的获益。

局限性

  • 为单中心回顾性研究,样本来自单一机构。
  • 平均随访2.74年,长期 durability 数据有限。
  • 再出血率与历史值比较,非同期对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment of ruptured cerebral aneurysms by endovascular coiling is associated with a better neurologic outcome when compared with neurosurgical clipping but has a higher risk for target aneurysm rebleeding after treatment. We hypothesize that aggressive retreatment of coiled aneurysms will lead to fewer recurrent hemorrhages as compared with historical values of 2.3%-3.0%. METHODS: All first-time Guglielmi detachable coil-embolized cerebral aneurysms were retrospectively reviewed at a single institution from 2004 to 2015. Aneurysm retreatment after first-time embolization was recorded as well as time to retreatment. Retreatment at our institution is routinely performed for incomplete coiling with etiologies including incomplete initial coiling, coil compaction, and aneurysmal dilatation. Aneurysm rerupture was treated with additional coiling. Kaplan-Meier survival analysis was performed to evaluate embolization durability. RESULTS: There were 214 aneurysms that met inclusion criteria. Mean (standard deviation) follow-up was 2.74 (2.24) years. Aneurysms that were patent or recanalized were retreated. Mean (standard deviation) time to retreatment was 9 (9) months. Overall, 46 (21.5%) aneurysms required retreatment. Retreatment was performed for coil compaction/remnant growth, recanalization, persistent remnant, and rebleed. Two (0.9%) patients had recurrent aneurysm hemorrhage and both were treated with additional coil embolization. There were no new long-term neurologic deficits caused by aneurysm retreatment. CONCLUSIONS: Aggressive retreatment of previously ruptured, coiled cerebral aneurysms for persistent aneurysm patency reduces the recurrent hemorrhage risk to that historically seen in neurosurgically clipped aneurysms with minimal additional morbidity. This study validates a large body of literature demonstrating the significance of post-treatment aneurysm remnants and their association with recurrent hemorrhage.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Mendenhall SK, Shapiro SA, Cohen-Gadol AA, et al. Endovascular Retreatment of Previously Ruptured Coiled Cerebral Aneurysm Remnants Significantly Reduces Rebleed Rate. World Neurosurg. 2020. PMID: 33352305. doi:10.1016/j.wneu.2020.12.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。